Fig. 2From: Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study Forest plot of primary and secondary outcomes . The dashed vertical line indicates no difference between the dapagliflozin and empagliflozin users . CIÂ confidence intervals, HRÂ hazard ratio, IRÂ incidence rateBack to article page